The conventional wisdom about quitting smoking had long held that the process was miserable — weeks of irritability, cravings, and the psychological weight of deprivation. This framing, while partly accurate about the transition period, obscured a more interesting finding that research was beginning to clarify by 2010: for many smokers, successfully quitting was associated with significant and durable improvements in mood, anxiety levels, and overall psychological wellbeing.

The finding was counterintuitive because nicotine is a mood-active substance, and smokers often reported that cigarettes relieved stress and improved focus. This self-report was accurate — nicotine did provide temporary mood improvement. What smokers typically failed to account for was the baseline: their resting anxiety and irritability levels were elevated by the cycle of nicotine dependence itself, so the cigarette that "relieved stress" was partly relieving the stress of not having a cigarette.

Studies comparing smokers, recent quitters, and lifelong non-smokers on standardized measures of anxiety, depression, and positive affect consistently found that non-smokers scored better on these measures than smokers — and that long-term ex-smokers scored comparably to lifelong non-smokers. The transition period was genuinely difficult, but it resolved into a psychological baseline that was better than the one the smoker had maintained.

This framing — quit smoking to feel better, not just to avoid disease — was increasingly incorporated into cessation programs by health professionals who recognized that health-risk messaging alone had limited motivational power, while the prospect of feeling genuinely better day-to-day was more compelling.

The data also showed that pharmacological support (varenicline, bupropion, nicotine replacement) significantly reduced withdrawal severity, making the difficult transition period shorter and more manageable.